Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society
Christoph Kowalski(German Cancer Society), Simone Wesselmann(Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie), Stefan Post(University of Mannheim), Jens‐Uwe Blohmer(Sankt Gertrauden Krankenhaus), Michael Ehrenfeld, Matthias W. Beckmann(Universitätsklinikum Erlangen), Hauke Lang(Johannes Gutenberg University Mainz), Uwe Schlegel(Defence Research and Development Organisation), D. Ukena(Klinikum Bremen-Mitte), Thomas Seufferlein(Universität Ulm), Heinrich Iro(Friedrich-Alexander-Universität Erlangen-Nürnberg), Stephan Grabbe(Johannes Gutenberg University Mainz), Walter Stummer(University of Münster), Ullrich Graeven(Kliniken Maria Hilf), Christof von Kalle(Luxembourg Institute of Health), Jan Fichtner(Klinik Niederrhein), Hans Hoffmann(TUM Klinikum), Anton Scharl(Klinikum St. Marien Amberg), Martin Burchardt(Universitätsmedizin Greifswald), Julia Ferencz
Cited by 110
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
|Oncogene|2007|1.9k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k